key: cord-1018983-ji2809f9 authors: Kannian, P.; Lavanya, C.; Ravichandran, K.; Jayaraman, B. G.; Mahanathi, P.; Ashwini, V.; Kumarasamy, N.; Rajan, G.; Ranganathan, K.; Challacombe, S. J.; Webster-Cyriaque, J.; Johnson, N. W. title: Detection of SARS-CoV2 antigen in human saliva may be a reliable tool for large scale screening date: 2020-12-19 journal: nan DOI: 10.1101/2020.12.17.20248437 sha: 1a56c6cbd3f0605b38296bc40d3de87ce48d04b2 doc_id: 1018983 cord_uid: ji2809f9 Introduction: SARS-CoV2, the aetiological agent of the current COVID-19 pandemic, has been detected in saliva and recently implicated in several oral diseases. Collection of nasopharyngeal swabs (NPS) and detection by reverse transcriptase-polymerase chain reaction (RT-PCR) requires medical / technical expertise. A reliable and easy to handle point-of-care (POC) test is highly desirable, especially to curb transmission. Therefore, in this study, we evaluated a commercially available POC rapid antigen test (RAT) for the detection of SARS-CoV2 antigens in the saliva of RT-PCR confirmed positive and negative patients. Methods: Thirty saliva samples of 10 saliva RT-PCR negative and 20 saliva RT-PCR positive patients were tested by RAT. Results: RAT was negative in 10/10 (100%) RT-PCR-negative samples; positive in 9/20 (45%) RT-PCR-positive samples; concordance was 63% (p=0.001). Patients with positive RAT had higher virus copies in their NPS samples compared to the RAT-negative patients. This difference was also statistically significant (p=0.01). Conclusion: Thus, the POC RAT may be used to detect SARS-CoV2 as a reliable tool for self-testing, large-scale population screening and emergency medical/dental screening. Patients negative by RAT should be confirmed by RT-PCR. It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint combined with its non-invasive method of self-collection, which does not require technical 23 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint expertise and has less risk of disease transmission, makes saliva an attractive choice as a 1 diagnostic specimen [9, 10] . Early and quick detection of SARS-CoV2 is of prime importance in 2 containing its spread. Most rapid antigen kits in commercial use are based on NPS specimens. 3 In this study we evaluated the utility of a SARS-CoV2 antigen kit using drooled saliva samples 4 from laboratory-confirmed SARS-CoV2 RT-PCR positive patients. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint All 10 RT-PCR negative saliva samples were negative for the presence of SARS-CoV2 antigens. 1 Of the 20 RT-PCR positive saliva samples, 9 (45%) were positive. The sensitivity, specificity 2 and concordance for the saliva antigen test were calculated against the saliva RT-PCR test. True 3 positives were 9/20 (45%). True negatives were 10/10 (100%). Therefore, the sensitivity was 4 45%, specificity 100% and concordance 63%: the last being statistically significant (p=0.001; 5 McNemar test). Antigen detection is generally less sensitive than RT-PCR. So, we compared 6 the SARS-CoV2 copies in the NPS of the patients with a negative or positive antigen test. The 7 median and interquartile range of the virus copies were markedly higher among the antigen 8 positive patients ( Figure 1 ) and this difference was statistically significant (p=0.01; Mann 9 Whitney rank sum test). and virus-infected cells thereby resulting is much less sensitivity. RT-PCR is a highly sensitive 21 method that detects the presence of viral RNA by million-fold amplification. RNA from dead 22 virus or unpackaged RNA will also be picked up by the RT-PCR. On the other hand, the antigen 23 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint test has moderate sensitivity due to the lack of any kind of amplification and detects the 1 translated proteins of the virus. Therefore, antigen positivity denotes abundance of proteins and 2 in turn high copy numbers as shown in the figure. The limitation in the use of saliva samples is 3 the requirement of a diligently collected free-flowing drooled sample without any sputum 4 contamination, as the thick phlegm/mucous can compromise the free lateral flow of the sample 5 across the chromatogram causing false negative results. 6 7 Overall, the point-of-care antigen test may be used for the detection of SARS-CoV2 in saliva 8 samples for the rapid confirmation in symptomatic cases requiring urgent medical care. In post-9 treatment or post-quarantine people this test might be very useful to rule out risk of transmission, 10 given that RT-PCR can remain positive for up to three months. Since this is a rapid, easy to use 11 point-of-care test it can also be advocated to be used at home as a self-test. It would also be 12 useful before invasive procedures, especially in dentistry, to assess the risk of transmission or in CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint Consistent detection of 2019 novel coronavirus in saliva Urgent 6 need of rapid tests for SARS-CoV2 antigen detection: Evaluation of the SD-Biosensor antigen 7 test for SARS-CoV2 Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To 14 Diagnose COVID-19 CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 19, 2020. ; https://doi.org/10.1101/2020.12.17.20248437 doi: medRxiv preprint